26 results match your criteria: "Blue Cross and Blue Shield Association Technology Evaluation Center[Affiliation]"
Implementing quality improvement strategies to reduce healthcare-associated infections: A systematic review.
Am J Infect Control
October 2014
Blue Cross and Blue Shield Association Technology Evaluation Center Evidence-Based Practice Center and Technology Evaluation Center, Blue Cross Blue Shield Association, Chicago, IL.
Background: Comprehensive incidence estimates indicate that 1.7 million healthcare-associated infections (HAIs) and 99,000 HAI-associated deaths occur in US hospitals. Preventing HAIs could save $25.
View Article and Find Full Text PDFChemotherapy sensitivity and resistance assays: a systematic review.
J Clin Oncol
September 2004
Blue Cross and Blue Shield Association Technology Evaluation Center, Washington, DC 20005, USA.
Purpose: This systematic review evaluates evidence comparing therapy guided by chemotherapy sensitivity and resistance assays with empiric chemotherapy, emphasizing survival outcomes.
Methods: Prospective studies were sought comparing patients treated contemporaneously by assay-guided chemotherapy and empiric therapy. An initial MEDLINE search and a search performed by a Working Group of the American Society of Clinical Oncology were reviewed with attention to prespecified study selection criteria.